Wedbush Starts Oncolytics Biotech (ONCY) at Outperform; New Class of Cancer Therapy Emerges
Tweet Send to a Friend
Wedbush initiates coverage on Oncolytics Biotech (NASDAQ: ONCY) with an Outperform. PT $9.
Wedbush analyst says, "Oncolytics Biotech is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Oncolytics Biotech is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
